Stoke Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of STOK for the last quarter is 4.89 M USD, and it's 1.30% higher compared to the previous quarter. The net income of Q3 24 is -26.43 M USD.